{"id":46349,"date":"2023-11-29T11:00:00","date_gmt":"2023-11-29T11:00:00","guid":{"rendered":"http:\/\/82fb1a7b6ac7d4cce927d50a6c02963f"},"modified":"2024-11-03T15:12:20","modified_gmt":"2024-11-03T15:12:20","slug":"esmo-immuno-oncology-congress-2023-6-8-december-2023-geneva-switzerland","status":"publish","type":"post","link":"https:\/\/ogkologos.com\/en\/esmo-immuno-oncology-congress-2023-6-8-december-2023-geneva-switzerland\/","title":{"rendered":"ESMO Immuno-Oncology Congress 2023, 6-8 December 2023, Geneva, Switzerland"},"content":{"rendered":"<p>LUGANO, Switzerland&nbsp;\u2013 The ESMO Immuno-Oncology Congress 2023, where experts discuss the latest scientific developments in this fast-moving field of cancer treatment, will be held in Geneva, Switzerland, between 6-8 December, also with a virtual component.<\/p>\n<h3>Programme highlights<\/h3>\n<ul>\n<li>Novel data, <a href=\"https:\/\/cslide.ctimeetingtech.com\/immuno2023\/attendee\/confcal\/session\/calendar\/2023-12-07\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">new insights<\/a>, and reinforced potential of the use of Tumour Infiltrating Lymphocytes (TIL) therapy in patients with melanoma<br \/>Related content: 119O, 48O, 50MO, 66MO, <a href=\"https:\/\/cslide.ctimeetingtech.com\/immuno2023\/attendee\/confcal\/session\/calendar\/2023-12-07\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Educational session<\/a> on Thursday, 7 December at 8:30 CET<\/li>\n<li>New therapeutic approaches in nasopharyngeal carcinoma and in relapsed\/refractory solid tumours<br \/>Related content: 67MO and 118O<\/li>\n<li>Further evidence of failures of Tyrosine Kinase Inhibitor (TKI) and Immune Checkpoint Inhibitors (CPI) combination in non-small cell lung cancer: Insights for future research directions<br \/>Related content: 64O, 65O, <a href=\"https:\/\/cslide.ctimeetingtech.com\/immuno2023\/attendee\/confcal\/session\/calendar?q=naidoo\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Educational session<\/a> on Wednesday, 6 December at 16:15 CET<\/li>\n<\/ul>\n<h3>Award keynote lecture<\/h3>\n<p>The results of 220 studies will be presented and published online as a supplement to <em>IOTECH<\/em>.<\/p>\n<h3>Press registration<\/h3>\n<p>ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the <a href=\"https:\/\/www.esmo.org\/newsroom\/press-and-media-policies\/esmo-policy-on-press-activities\" class>ESMO Policy on Press Activities<\/a>. To apply for press accreditation, please fill out the form available <a href=\"https:\/\/press-portal.esmo.org\/#\/accreditation?meeting=7366&amp;callbackUrl=https:\/\/www.esmo.org\/newsroom\/esmo-press-office\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">here<\/a>. Requests for press accreditation should be sent by Tuesday, 5 December. Please be kindly informed that onsite press accreditation will not be possible.<\/p>\n<h3>Further information<\/h3>\n<p>ESMO Press Office<br \/><a href=\"mailto:press@esmo.org\" target=\"_blank\" rel=\"noopener noreferrer\" class>press@esmo.org<\/a><\/p>\n<h3>Notes to editors<\/h3>\n<p>Please make sure to use the official name of the meeting in your reports: <strong>ESMO Immuno-Oncology Congress 2023<\/strong> and the official congress hashtag <strong>#ESMOImmuno23<\/strong>. Follow it to stay up to date and use it to take part in the conversation on <a href=\"https:\/\/twitter.com\/myESMO?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">X (Twitter)<\/a>, <a href=\"https:\/\/www.linkedin.com\/company\/european-society-for-medical-oncology\/\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">LinkedIn<\/a>, <a href=\"https:\/\/www.instagram.com\/esmo_eur_oncology\/\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Instagram<\/a>, <a href=\"https:\/\/www.facebook.com\/esmo.org\/\" target=\"_blank\" rel=\"noopener noreferrer\" class=\"external-link\">Facebook<\/a>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.esmo.org\/newsroom\/press-releases\/esmo-immuno-oncology-congress-2023-6-8-december-2023-geneva-switzerland\">Source<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>LUGANO, Switzerland&nbsp;\u2013 The ESMO Immuno-Oncology Congress 2023, where experts discuss the latest scientific developments in this fast-moving field of cancer treatment, will be held in Geneva, Switzerland, between 6-8 December, also with a virtual component. Programme highlights Novel data, new insights, and reinforced potential of the use of Tumour Infiltrating Lymphocytes (TIL) therapy in patients [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[5137],"tags":[],"class_list":["post-46349","post","type-post","status-publish","format-standard","hentry","category-world-news"],"_links":{"self":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/comments?post=46349"}],"version-history":[{"count":1,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46349\/revisions"}],"predecessor-version":[{"id":46366,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/posts\/46349\/revisions\/46366"}],"wp:attachment":[{"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/media?parent=46349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/categories?post=46349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ogkologos.com\/en\/wp-json\/wp\/v2\/tags?post=46349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}